NO314070B1 - Hemostatisk svamp basert på kollagen, fremgangsmåte for fremstilling av denne, samt sett og sårbeskyttelse som omfatter denne - Google Patents
Hemostatisk svamp basert på kollagen, fremgangsmåte for fremstilling av denne, samt sett og sårbeskyttelse som omfatter denne Download PDFInfo
- Publication number
- NO314070B1 NO314070B1 NO19984619A NO984619A NO314070B1 NO 314070 B1 NO314070 B1 NO 314070B1 NO 19984619 A NO19984619 A NO 19984619A NO 984619 A NO984619 A NO 984619A NO 314070 B1 NO314070 B1 NO 314070B1
- Authority
- NO
- Norway
- Prior art keywords
- sponge
- collagen
- thrombin
- mixture
- weight
- Prior art date
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 53
- 108010035532 Collagen Proteins 0.000 title claims abstract description 53
- 229920001436 collagen Polymers 0.000 title claims abstract description 53
- 230000002439 hemostatic effect Effects 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 title claims description 17
- 238000002360 preparation method Methods 0.000 title description 6
- 241000233866 Fungi Species 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 230000023555 blood coagulation Effects 0.000 claims abstract description 11
- 239000012190 activator Substances 0.000 claims abstract description 9
- 230000002760 pro-activator Effects 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 108090000190 Thrombin Proteins 0.000 claims description 48
- 229960004072 thrombin Drugs 0.000 claims description 48
- 108010049003 Fibrinogen Proteins 0.000 claims description 27
- 102000008946 Fibrinogen Human genes 0.000 claims description 27
- 229940012952 fibrinogen Drugs 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 19
- 238000004108 freeze drying Methods 0.000 claims description 15
- 239000000512 collagen gel Substances 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000007710 freezing Methods 0.000 claims description 7
- 108010094028 Prothrombin Proteins 0.000 claims description 6
- 102100027378 Prothrombin Human genes 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000008240 homogeneous mixture Substances 0.000 claims description 6
- 229940039716 prothrombin Drugs 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 229920005862 polyol Polymers 0.000 claims description 4
- 150000003077 polyols Chemical class 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108010074860 Factor Xa Proteins 0.000 claims description 2
- 238000004026 adhesive bonding Methods 0.000 claims description 2
- 239000000504 antifibrinolytic agent Substances 0.000 claims description 2
- 229940121375 antifungal agent Drugs 0.000 claims description 2
- 229910001424 calcium ion Inorganic materials 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- 229940088598 enzyme Drugs 0.000 claims description 2
- 239000002532 enzyme inhibitor Substances 0.000 claims description 2
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 238000007605 air drying Methods 0.000 claims 1
- 239000003429 antifungal agent Substances 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229940125532 enzyme inhibitor Drugs 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000000463 material Substances 0.000 description 22
- 206010052428 Wound Diseases 0.000 description 20
- 208000027418 Wounds and injury Diseases 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- 239000010410 layer Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 230000000740 bleeding effect Effects 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 239000003106 tissue adhesive Substances 0.000 description 7
- 108010071289 Factor XIII Proteins 0.000 description 6
- 108010073385 Fibrin Proteins 0.000 description 6
- 102000009123 Fibrin Human genes 0.000 description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940012444 factor xiii Drugs 0.000 description 6
- 229950003499 fibrin Drugs 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 241000700605 Viruses Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 108010034963 tachocomb Proteins 0.000 description 4
- 229940075469 tissue adhesives Drugs 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 241000282887 Suidae Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
- 101800004937 Protein C Proteins 0.000 description 2
- 102000017975 Protein C Human genes 0.000 description 2
- 101800001700 Saposin-D Proteins 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 230000001567 anti-fibrinolytic effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000000515 collagen sponge Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000003480 fibrinolytic effect Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000000937 inactivator Effects 0.000 description 2
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229960000856 protein c Drugs 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960003766 thrombin (human) Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- NPUKDXXFDDZOKR-UHFFFAOYSA-N 3-(1-phenylethyl)-4-imidazolecarboxylic acid ethyl ester Chemical compound CCOC(=O)C1=CN=CN1C(C)C1=CC=CC=C1 NPUKDXXFDDZOKR-UHFFFAOYSA-N 0.000 description 1
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
- 102000004411 Antithrombin III Human genes 0.000 description 1
- 108090000935 Antithrombin III Proteins 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010048049 Factor IXa Proteins 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229940122791 Plasmin inhibitor Drugs 0.000 description 1
- 108010077971 Plasminogen Inactivators Proteins 0.000 description 1
- 102000010752 Plasminogen Inactivators Human genes 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 241000125945 Protoparvovirus Species 0.000 description 1
- 229940122055 Serine protease inhibitor Drugs 0.000 description 1
- 101710102218 Serine protease inhibitor Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108010000499 Thromboplastin Proteins 0.000 description 1
- 102000002262 Thromboplastin Human genes 0.000 description 1
- 206010048629 Wound secretion Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 108010018823 anti-inhibitor coagulant complex Proteins 0.000 description 1
- 229940082620 antifibrinolytics Drugs 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229960005348 antithrombin iii Drugs 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229940019700 blood coagulation factors Drugs 0.000 description 1
- 239000003914 blood derivative Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 238000013130 cardiovascular surgery Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 108010033702 ethnor Proteins 0.000 description 1
- 229940105776 factor viii inhibitor bypassing activity Drugs 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 108010011227 meizothrombin Proteins 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000004738 parenchymal cell Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 239000002806 plasmin inhibitor Substances 0.000 description 1
- 239000002797 plasminogen activator inhibitor Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000003805 procoagulant Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108010014806 prothrombinase complex Proteins 0.000 description 1
- 239000003001 serine protease inhibitor Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 239000003869 thrombin derivative Substances 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 229940033618 tisseel Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0036—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/102—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/08—Collagen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/22—Blood coagulation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Surgery (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT61196 | 1996-04-04 | ||
| PCT/EP1997/001662 WO1997037694A1 (en) | 1996-04-04 | 1997-04-02 | Hemostatic sponge based on collagen |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO984619D0 NO984619D0 (no) | 1998-10-02 |
| NO984619L NO984619L (no) | 1998-12-03 |
| NO314070B1 true NO314070B1 (no) | 2003-01-27 |
Family
ID=3495187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19984619A NO314070B1 (no) | 1996-04-04 | 1998-10-02 | Hemostatisk svamp basert på kollagen, fremgangsmåte for fremstilling av denne, samt sett og sårbeskyttelse som omfatter denne |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6649162B1 (sk) |
| EP (1) | EP0891193B1 (sk) |
| JP (2) | JP2000510357A (sk) |
| AT (1) | ATE247494T1 (sk) |
| AU (1) | AU726163B2 (sk) |
| CA (1) | CA2251475C (sk) |
| CZ (1) | CZ318998A3 (sk) |
| DE (1) | DE69724243T2 (sk) |
| HU (1) | HUP9903586A3 (sk) |
| NO (1) | NO314070B1 (sk) |
| RU (1) | RU2193897C2 (sk) |
| SK (1) | SK284693B6 (sk) |
| WO (1) | WO1997037694A1 (sk) |
Families Citing this family (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
| US7435425B2 (en) | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
| US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
| DE10025001A1 (de) * | 2000-05-22 | 2001-11-29 | Aventis Behring Gmbh | Gewebekleber mit verbesserten anti-adhäsiven Eigenschaften |
| DE60032001T2 (de) * | 1999-09-27 | 2007-05-31 | Sysmex Corp. | Verfahren zur stabilisierung von thrombin |
| CA2400398C (en) * | 2000-03-09 | 2010-05-04 | Syntacoll Ag | Multilayer collagen matrix for tissue reconstruction |
| US7727547B2 (en) * | 2000-04-04 | 2010-06-01 | Tissuemed Limited | Tissue-adhesive formulations |
| AT411326B (de) * | 2000-06-20 | 2003-12-29 | Biering Wolfgang | Hämostatische collagen-pellets |
| US6890342B2 (en) | 2000-08-02 | 2005-05-10 | Loma Linda University | Method and apparatus for closing vascular puncture using hemostatic material |
| ATE286408T1 (de) * | 2000-10-23 | 2005-01-15 | Tissuemed Ltd | Selbstklebende, hydratierbare matrix für therapeutische anwendungen |
| MXPA03006687A (es) * | 2001-01-25 | 2004-03-12 | Nycomed Pharma As | Un metodo para preparar una esponja de colageno, un dispositivo para extraer una parte de una espuma de colageno y una de colageno alargada. |
| US7098315B2 (en) | 2001-01-25 | 2006-08-29 | Nycomed Pharma As | Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| US6733774B2 (en) | 2001-01-25 | 2004-05-11 | Nycomed Pharma As | Carrier with solid fibrinogen and solid thrombin |
| US7052713B2 (en) | 2001-02-13 | 2006-05-30 | Nycomed Pharma As | Carrier with solid fibrinogen and solid thrombin |
| US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
| EP1501558A1 (de) * | 2002-05-08 | 2005-02-02 | Rheinisch-Westfälische Technische Hochschule Aachen (RWTH) | Resorbierbare pharmazeutische formulierung zur kontinuierlichen thrombinfreisetzung |
| WO2003105697A1 (en) | 2002-06-14 | 2003-12-24 | Loma Linda University Medical Center | Vascular wound closure device and method |
| US20040106344A1 (en) * | 2002-06-28 | 2004-06-03 | Looney Dwayne Lee | Hemostatic wound dressings containing proteinaceous polymers |
| CA2509914A1 (en) | 2002-12-11 | 2004-06-24 | Ferrosan A/S | Gelatine-based materials as swabs |
| US20040122349A1 (en) | 2002-12-20 | 2004-06-24 | Lafontaine Daniel M. | Closure device with textured surface |
| US8709038B2 (en) | 2002-12-20 | 2014-04-29 | Boston Scientific Scimed, Inc. | Puncture hole sealing device |
| KR101213460B1 (ko) * | 2003-01-20 | 2012-12-20 | 잇판자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 지혈용 재료 |
| US8834864B2 (en) | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
| US7942897B2 (en) | 2003-07-10 | 2011-05-17 | Boston Scientific Scimed, Inc. | System for closing an opening in a body cavity |
| US7927626B2 (en) | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| EP2345371B1 (en) | 2003-08-14 | 2014-07-16 | Loma Linda University Medical Center | Vascular wound closure device |
| US8187627B2 (en) * | 2003-09-05 | 2012-05-29 | Loma Linda University Medical Center | Dressing delivery system for internal wounds |
| JP2007519450A (ja) | 2004-01-30 | 2007-07-19 | フェロサン アー／エス | 止血用のスプレーおよび組成物 |
| JPWO2005113030A1 (ja) * | 2004-05-21 | 2008-07-31 | 財団法人化学及血清療法研究所 | 組織閉鎖剤 |
| CN101001649B (zh) | 2004-07-09 | 2011-08-31 | 弗罗桑医疗设备公司 | 包括透明质酸的止血组合物及其制备方法 |
| MX2007001554A (es) * | 2004-08-03 | 2007-04-10 | Tissuemed Ltd | Materiales adhesivos a tejido. |
| US9358318B2 (en) * | 2004-10-20 | 2016-06-07 | Ethicon, Inc. | Method of making a reinforced absorbable multilayered hemostatic wound dressing |
| EP2345430B1 (en) * | 2004-10-20 | 2015-11-25 | Ethicon, Inc. | A reinforced absorbable multilayered fabric for use in medical devices and method of manufacture |
| US20060257457A1 (en) * | 2004-10-20 | 2006-11-16 | Gorman Anne J | Method for making a reinforced absorbable multilayered hemostatic wound dressing |
| WO2006044882A2 (en) * | 2004-10-20 | 2006-04-27 | Ethicon, Inc. | A reinforced absorbable multilayered hemostatic wound dressing and method of making |
| US20060258995A1 (en) * | 2004-10-20 | 2006-11-16 | Pendharkar Sanyog M | Method for making a reinforced absorbable multilayered fabric for use in medical devices |
| CA2590783A1 (en) * | 2004-12-14 | 2006-06-22 | Fidia Advanced Biopolymers S.R.L. | Process for the preparation of two and three dimensional polymer scaffolds |
| US20060142798A1 (en) * | 2004-12-27 | 2006-06-29 | Holman Thomas J | Device and method for closing an opening in a body cavity or lumen |
| KR20100102750A (ko) | 2005-04-25 | 2010-09-24 | 메사추세츠 인스티튜트 오브 테크놀로지 | 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법 |
| JP2006306759A (ja) * | 2005-04-27 | 2006-11-09 | Fujimori Kogyo Co Ltd | トロンビン医薬製剤 |
| US7429241B2 (en) | 2005-09-29 | 2008-09-30 | Codman & Shurtleff, Inc. | Dural graft and method of preparing the same |
| WO2007044510A1 (en) | 2005-10-05 | 2007-04-19 | Loma Linda University Medical Center | Vascular wound closure device and method |
| US8133336B2 (en) | 2006-02-03 | 2012-03-13 | Tissuemed Limited | Tissue-adhesive materials |
| US20090018575A1 (en) * | 2006-03-01 | 2009-01-15 | Tissuemed Limited | Tissue-adhesive formulations |
| EP3115070B8 (en) | 2006-03-23 | 2019-05-08 | The Penn State Research Foundation | Heart assist device with expandable impeller pump |
| JP2009535338A (ja) | 2006-04-25 | 2009-10-01 | マサチューセッツ・インスティテュート・オブ・テクノロジー | 汚染因子、体液または他の実体の動きに影響を及ぼし、そして／あるいは他の生理学的状態に影響を及ぼすための組成物および方法 |
| CN101454030B (zh) | 2006-05-31 | 2013-06-26 | 巴克斯特国际公司 | 用于脊柱外科手术中定向细胞向内生长和控制组织再生的方法 |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
| WO2008019128A2 (en) | 2006-08-04 | 2008-02-14 | Stb Lifesaving Technologies, Inc. | Solid dressing for treating wounded tissue |
| JP5581056B2 (ja) | 2006-12-15 | 2014-08-27 | ライフボンド リミテッド | ゼラチン−トランスグルタミナーゼ止血ドレッシング及びシーラント |
| DE102007037051A1 (de) * | 2007-07-24 | 2009-01-29 | Aesculap Ag | Flächiges Implantat |
| CN101842122B (zh) | 2007-10-30 | 2013-12-25 | 巴克斯特国际公司 | 再生性生物功能胶原生物基质用于治疗内脏或腔壁缺损的应用 |
| CN102014973A (zh) | 2008-02-29 | 2011-04-13 | 弗罗桑医疗设备公司 | 用于促进止血和/或伤口愈合的装置 |
| JP5437236B2 (ja) | 2008-04-16 | 2014-03-12 | 一般財団法人化学及血清療法研究所 | トロンビン固定化生体吸収性シート製剤の製造方法 |
| JP5450612B2 (ja) | 2008-06-18 | 2014-03-26 | ライフボンド リミテッド | 改良された架橋組成物 |
| SG194405A1 (en) | 2008-10-06 | 2013-11-29 | 3 D Matrix Ltd | Tissue occluding agent |
| AU2010207472B2 (en) * | 2009-01-23 | 2015-05-21 | Royal College Of Surgeons In Ireland | Layered scaffold suitable for osteochondral repair |
| US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
| EP2441477B1 (en) * | 2009-06-11 | 2019-02-13 | KM Biologics Co., Ltd. | Wound-covering material |
| KR101699992B1 (ko) | 2009-06-16 | 2017-01-26 | 백스터 인터내셔널 인코포레이티드 | 지혈용 스펀지 |
| US9271925B2 (en) | 2013-03-11 | 2016-03-01 | Bioinspire Technologies, Inc. | Multi-layer biodegradable device having adjustable drug release profile |
| WO2011035020A1 (en) | 2009-09-18 | 2011-03-24 | Bioinspire Technologies, Inc. | Free-standing biodegradable patch |
| DE102009053305A1 (de) | 2009-11-12 | 2011-08-18 | medichema GmbH, 09112 | Verfahren zur Herstellung einer schichtförmigen Wundauflage |
| WO2011072482A1 (en) | 2009-12-14 | 2011-06-23 | The University Of Hong Kong | Nano cancer barrier device(ncbd) to immobilize and inhibit the division of metastic cancer stem cells |
| AU2010339045B2 (en) | 2009-12-16 | 2014-06-05 | Baxter Healthcare S.A. | Hemostatic sponge |
| EP2515957B1 (en) | 2009-12-22 | 2015-07-29 | Lifebond Ltd | Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices |
| CA2790248A1 (en) | 2010-03-15 | 2011-09-22 | Ferrosan Medical Devices A/S | A method for promotion of hemostasis and/or wound healing |
| SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
| AU2011260274B2 (en) | 2010-06-01 | 2015-07-02 | Baxter Healthcare S.A. | Process for making dry and stable hemostatic compositions |
| AU2011260258B2 (en) | 2010-06-01 | 2015-07-09 | Baxter Healthcare S.A. | Process for making dry and stable hemostatic compositions |
| MX345479B (es) | 2010-06-01 | 2017-02-01 | Baxter Int Inc * | Proceso para elaborar composiciones hemostaticas secas y estables. |
| KR101865160B1 (ko) * | 2010-07-20 | 2018-06-07 | 잇빤 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 조직 접착용 시트 제제 |
| US8961544B2 (en) | 2010-08-05 | 2015-02-24 | Lifebond Ltd. | Dry composition wound dressings and adhesives comprising gelatin and transglutaminase in a cross-linked matrix |
| DE102010038155A1 (de) | 2010-10-05 | 2012-04-05 | Technische Universität Ilmenau | Einem biologischen Gewebe nachgebildete Struktur und Verfahren zu deren Herstellung |
| CN102357259A (zh) * | 2011-07-28 | 2012-02-22 | 王珊珊 | 一种生物蛋白海绵及其制备方法 |
| WO2013048787A1 (en) * | 2011-09-26 | 2013-04-04 | Yes, Inc. | Novel hemostatic compositions and dressings for bleeding |
| WO2013053755A2 (en) | 2011-10-11 | 2013-04-18 | Baxter International Inc. | Hemostatic compositions |
| AU2012318257B2 (en) | 2011-10-11 | 2015-10-01 | Baxter Healthcare S.A. | Hemostatic compositions |
| ES2553702T3 (es) | 2011-10-27 | 2015-12-11 | Baxter International Inc | Composiciones hemostáticas |
| CA2865349C (en) | 2012-03-06 | 2021-07-06 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
| EP2825216B1 (en) | 2012-06-12 | 2015-08-19 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
| US10793307B2 (en) | 2012-07-06 | 2020-10-06 | 3-D Matrix, Ltd. | Fill-finish process for peptide solutions |
| CN105358071B (zh) | 2013-06-21 | 2018-07-31 | 弗罗桑医疗设备公司 | 真空膨胀的干组合物和用于保留该干组合物的注射器 |
| IL229645A0 (en) * | 2013-11-26 | 2014-03-31 | Omrix Biopharmaceuticals Ltd | A dry bandage containing thrombin and pectin |
| CN105828844B (zh) | 2013-12-11 | 2019-09-27 | 弗罗桑医疗设备公司 | 包含挤出增强剂的干组合物 |
| WO2015136370A2 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Sterilization and filtration of peptide compositions |
| ES2712608T3 (es) | 2014-03-10 | 2019-05-14 | 3 D Matrix Ltd | Péptidos autoensamblantes para el tratamiento de las bullas pulmonares |
| AU2015229549B2 (en) | 2014-03-10 | 2019-05-23 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
| DE102014106711A1 (de) | 2014-05-13 | 2015-11-19 | Bayer Innovation Gmbh | Verwendung von siliziumhaltigen Fasern und/oder einer Fasermatrix als bioresorbierbares Wundvlies |
| KR101536134B1 (ko) * | 2014-09-26 | 2015-07-14 | 세원셀론텍(주) | 연부조직 수복용 매트릭스의 제조방법 |
| CN106999621B (zh) | 2014-10-13 | 2020-07-03 | 弗罗桑医疗设备公司 | 用于止血和伤口愈合的干组合物 |
| AU2015371184B2 (en) | 2014-12-24 | 2020-06-25 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
| KR101664415B1 (ko) * | 2015-01-12 | 2016-10-12 | 주식회사 한국비엔씨 | 약물을 포함하는 콜라겐 창상피복재 및 이의 제조방법 |
| WO2016130559A1 (en) | 2015-02-10 | 2016-08-18 | Lifenet Health | Biologically functional soft tissue scaffolds and implants |
| CN117357712A (zh) * | 2015-02-27 | 2024-01-09 | 聚合物器官 Ip 股份有限公司 | 药物洗脱泡沫及其生产 |
| BR112017027695A2 (pt) | 2015-07-03 | 2018-09-04 | Ferrosan Medical Devices As | seringa para retenção e mistura de primeira e segunda substâncias |
| US10814038B2 (en) | 2016-01-06 | 2020-10-27 | 3-D Matrix, Ltd. | Combination compositions |
| WO2018165409A1 (en) | 2017-03-09 | 2018-09-13 | Baxter International Inc. | Solvent deposition system and methods |
| RU176884U1 (ru) * | 2017-09-25 | 2018-01-31 | Павел Борисович Панов | Кровоостанавливающий пакет |
| WO2019116092A1 (en) | 2017-12-15 | 2019-06-20 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses in drug delivery |
| ES2968412T3 (es) | 2018-05-09 | 2024-05-09 | Ferrosan Medical Devices As | Método para preparar una composición hemostática |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
| RU2701195C1 (ru) * | 2018-11-28 | 2019-09-25 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) | Способ получения искусственных губок в микропробирках для проведения лабораторных исследований in vitro |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1717118A1 (de) * | 1964-05-16 | 1972-10-19 | Spofa Vereinigte Pharma Werke | Verfahren zur Herstellung von Kollagenschaum |
| US3514518A (en) * | 1967-12-19 | 1970-05-26 | Pierre Charier Vadrot | Process for preparation of gelatinous material from animal collagen |
| US3823212A (en) * | 1968-11-27 | 1974-07-09 | Freudenberg C Fa | Process for the production of collagen fiber fabrics in the form of felt-like membranes or sponge-like layers |
| US4390519A (en) * | 1978-05-19 | 1983-06-28 | Sawyer Philip Nicholas | Bandage with hemostatic agent and methods for preparing and employing the same |
| US4404970A (en) * | 1978-05-19 | 1983-09-20 | Sawyer Philip Nicholas | Hemostatic article and methods for preparing and employing the same |
| US4279812A (en) * | 1979-09-12 | 1981-07-21 | Seton Company | Process for preparing macromolecular biologically active collagen |
| DE3019612A1 (de) * | 1980-05-22 | 1981-11-26 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisiertes thrombinpraeparat |
| CA1156529A (en) * | 1980-06-12 | 1983-11-08 | Fred A. Serravallo | Fibrous collagenous hemostatic-adhesive webs |
| US4292972A (en) * | 1980-07-09 | 1981-10-06 | E. R. Squibb & Sons, Inc. | Lyophilized hydrocolloio foam |
| DE3037513C2 (de) * | 1980-10-03 | 1983-05-05 | Steffan, Wolfgang, 8425 Neustadt | Kollagene Wundauflage |
| DE3105624A1 (de) * | 1981-02-16 | 1982-09-02 | Hormon-Chemie München GmbH, 8000 München | Material zum abdichten und heilen von wunden |
| DE3212412C2 (de) * | 1982-04-02 | 1986-01-02 | Dr. Ruhland Nachf. GmbH, 8425 Neustadt | Gewebeverklebbare kollagene Wundauflage |
| US4515637A (en) * | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
| US4600574A (en) * | 1984-03-21 | 1986-07-15 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Method of producing a tissue adhesive |
| US4925924A (en) * | 1984-03-27 | 1990-05-15 | University Of Medicine And Dentistry Of New Jersey | Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof |
| US4606910A (en) * | 1984-06-28 | 1986-08-19 | Interface Biomedical Laboratories | Composite hemostatic article including a hemostatic agent onlay and methods for preparing the same |
| DE3533423A1 (de) | 1985-09-19 | 1987-03-26 | Wolf Gmbh Richard | Applikator-zangeneinsatz fuer chirurgische handhabe zur anwendung in der endoskopie |
| US4696812A (en) * | 1985-10-28 | 1987-09-29 | Warner-Lambert Company | Thrombin preparations |
| ZA88227B (en) * | 1987-01-28 | 1988-06-30 | Warner-Lambert Company | Thrombin preparations |
| JPS6440433A (en) * | 1987-08-05 | 1989-02-10 | Green Cross Corp | Aqueous liquid composition of thrombin |
| US4891359A (en) * | 1988-12-08 | 1990-01-02 | Johnson & Johnson Patient Care, Inc. | Hemostatic collagen paste composition |
| DK223389D0 (da) | 1989-05-05 | 1989-05-05 | Ferrosan As | Saarsvamp |
| JPH039747U (sk) * | 1989-06-20 | 1991-01-30 | ||
| FR2679778B1 (fr) * | 1991-08-02 | 1995-07-07 | Coletica | Utilisation de collagene reticule par un agent de reticulation pour la fabrication d'une membrane suturable, biocompatible, a resorption lente, ainsi qu'une telle membrane. |
| US5331092A (en) * | 1992-11-06 | 1994-07-19 | Coletica | Process of preparation of collagen containing in major proportion insoluble collagen and collagen having high mechanical resistance and thermal stability obtained thereby |
| JP3172289B2 (ja) | 1992-11-18 | 2001-06-04 | 三洋電機株式会社 | 熱交換ユニット |
| US5836970A (en) * | 1996-08-02 | 1998-11-17 | The Kendall Company | Hemostatic wound dressing |
-
1997
- 1997-04-02 CA CA002251475A patent/CA2251475C/en not_active Expired - Lifetime
- 1997-04-02 US US09/155,569 patent/US6649162B1/en not_active Expired - Lifetime
- 1997-04-02 AT AT97918102T patent/ATE247494T1/de not_active IP Right Cessation
- 1997-04-02 DE DE69724243T patent/DE69724243T2/de not_active Expired - Lifetime
- 1997-04-02 CZ CZ983189A patent/CZ318998A3/cs unknown
- 1997-04-02 JP JP09535819A patent/JP2000510357A/ja not_active Withdrawn
- 1997-04-02 HU HU9903586A patent/HUP9903586A3/hu unknown
- 1997-04-02 EP EP97918102A patent/EP0891193B1/en not_active Expired - Lifetime
- 1997-04-02 AU AU26359/97A patent/AU726163B2/en not_active Expired
- 1997-04-02 SK SK1373-98A patent/SK284693B6/sk not_active IP Right Cessation
- 1997-04-02 RU RU98119893/14A patent/RU2193897C2/ru not_active IP Right Cessation
- 1997-04-02 WO PCT/EP1997/001662 patent/WO1997037694A1/en not_active Application Discontinuation
-
1998
- 1998-10-02 NO NO19984619A patent/NO314070B1/no not_active IP Right Cessation
-
2009
- 2009-10-29 JP JP2009248693A patent/JP5373553B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE247494T1 (de) | 2003-09-15 |
| CA2251475A1 (en) | 1997-10-16 |
| JP5373553B2 (ja) | 2013-12-18 |
| RU2193897C2 (ru) | 2002-12-10 |
| CZ318998A3 (cs) | 1999-09-15 |
| DE69724243T2 (de) | 2004-06-17 |
| JP2010046516A (ja) | 2010-03-04 |
| EP0891193B1 (en) | 2003-08-20 |
| CA2251475C (en) | 2006-09-05 |
| WO1997037694A1 (en) | 1997-10-16 |
| EP0891193A1 (en) | 1999-01-20 |
| NO984619D0 (no) | 1998-10-02 |
| SK137398A3 (en) | 1999-03-12 |
| NO984619L (no) | 1998-12-03 |
| AU726163B2 (en) | 2000-11-02 |
| SK284693B6 (sk) | 2005-09-08 |
| AU2635997A (en) | 1997-10-29 |
| HUP9903586A2 (hu) | 2000-03-28 |
| DE69724243D1 (de) | 2003-09-25 |
| US6649162B1 (en) | 2003-11-18 |
| JP2000510357A (ja) | 2000-08-15 |
| HUP9903586A3 (en) | 2003-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU726163B2 (en) | Hemostatic sponge based on collagen | |
| JP3602441B2 (ja) | フィブリンスポンジ | |
| TWI511753B (zh) | 止血棉 | |
| KR101811070B1 (ko) | 지혈 스폰지 | |
| JP5719355B2 (ja) | 止血スポンジ | |
| CN105828844B (zh) | 包含挤出增强剂的干组合物 | |
| EP3496769B1 (en) | Hemostatic compositions and methods of making thereof | |
| EP3752212B1 (en) | Method of making hemostatic compositions | |
| CN101854960A (zh) | 明胶-转谷氨酰胺酶止血敷料和密封材料 | |
| EP3074055B1 (en) | Dry pad comprising thrombin and pectin | |
| JP2020509802A (ja) | 溶媒デポジションシステム及び方法 | |
| JPH0199565A (ja) | フィブリン糊調製用キット | |
| US20220111020A1 (en) | Hemostatic compositions and methods of making thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |